The effect of Origanum majorana tea on motor and non-motor symptoms in patients with idiopathic Parkinson's disease: A randomized controlled pilot study.
BDI
NMSS
Origanum majorana
Parkinson's disease
UPDRSIII
Journal
Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
31
03
2021
revised:
16
08
2021
accepted:
22
08
2021
pubmed:
30
8
2021
medline:
9
2
2022
entrez:
29
8
2021
Statut:
ppublish
Résumé
The effect of Origanum majorana tea consumption on motor and non-motor symptoms was investigated in patients with idiopathic Parkinson's disease, measured by validated tools. Sixty patients with idiopathic Parkinson's disease and under conventional medication were enrolled voluntarily in the study. All participants were randomized on double-blind to placebo or Origanum majorana. Clinical assessment with validated tools (UPDRSIII, NMSS, and BDI) was done before Origanum majorana or placebo consumption (Day 0) and at the end of the experiment (Day 30). The treatment groups were similar at baseline on demographic and clinical variables. During the course of study, nine participants withdrew for reasons of noncompliance and inability to follow-up. Fifty-one participants completed the study. Upon completion of 30 days of treatment, Origanum majorana tea consumption did not decrease the UPDRSIII score ([UPDRSIII
Identifiants
pubmed: 34455218
pii: S1353-8020(21)00307-2
doi: 10.1016/j.parkreldis.2021.08.013
pii:
doi:
Substances chimiques
Tea
0
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
23-27Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.